George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: -0.25 (-3.33%)
Spread: 0.50 (7.143%)
Open: 7.55
High: 7.55
Low: 7.25
Prev. Close: 7.50
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Open Offer, General Meeting and TVR

25 May 2023 14:48

RNS Number : 7002A
Kromek Group PLC
25 May 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to The Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Not for publication, distribution or release directly or indirectly, in whole or in part, in or into the United States of America, Canada, Russia, Australia, Japan, the Republic of Ireland, the Republic of South Africa, New Zealand, Cayman Islands, Barbados, Switzerland, the State of Kuwait or Singapore in or into any other jurisdiction where offers or sales would be prohibited by applicable law. This announcement is for information purposes only and is not an offer to sell or a solicitation to buy securities in Kromek Group plc or any other entity in any jurisdiction, including the United States of America, Canada, Russia, Australia, Japan, the Republic of Ireland, the Republic of South Africa, New Zealand, Cayman Islands, Barbados, Switzerland, the State of Kuwait or Singapore.

 

 

Kromek Group plc

("Kromek", the "Company" or the "Group")

 

Result of Oversubscribed Open Offer, General Meeting

 

and

 

Total Voting Rights

 

Kromek (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that at its General Meeting held earlier today all resolutions, as set out in the Circular dated 9 May 2023 relating to a conditional Placing and Subscription to raise £7.0 million and an Open Offer to raise up to an additional £1.0 million, were duly passed. The Company is also pleased to announce that it has raised £1.0 million via the Open Offer and, accordingly, has raised total gross proceeds of approximately £8.0 million through the Transaction. 

The Open Offer closed for acceptances at 11.00 a.m. on 23 May 2023 and was oversubscribed. Valid acceptances have been received in respect of 74,749,006 Open Offer Shares, representing approximately 363 per cent. of the Open Offer Shares available under the Open Offer. In accordance with the terms and conditions of the Open Offer, all applications made pursuant to the Open Offer (other than Excess Shares applied for under the Excess Application Facility) have been met in full and a scaling back exercise has been undertaken in respect of applications for Excess Shares. The Company has therefore raised gross proceeds of approximately £1.0 million through the Open Offer.

As set out in the Circular dated 9 May 2023, certain Directors of the Company indicated their intention to participate in the Transaction. Following the completion of the Transaction and on Admission, their interests in Ordinary Shares will be as follows:

Director

Position

Number of Ordinary Shares held prior to the Transaction

Number of Ordinary Shares held as a percentage of the Existing Ordinary Share Capital

Number of Directors' Subscription Shares subscribed for

Number of Shares under the Placing

Number of Ordinary Shares held following the Transaction

Percentage of Ordinary Shares held following the Transaction

Rakesh Sharma*

Chairman

807,539

0.19%

400,000

-

1,207,539

0.20%

Arnab Basu

Chief Executive Officer

2,988,750

0.69%

100,000

-

3,088,750

0.52%

Paul Farquhar

Chief Financial Officer

66,500

0.02%

-

100,000

166,500

0.03%

Lawrence Kinet

Non-Executive Director

350,000

0.08%

400,000

-

750,000

0.13%

Jerel Whittingham

Non-Executive Director

364,890

0.08%

300,000

-

664,890

0.11%

Christopher Wilks

Non-Executive Director

177,941

0.04%

100,000

-

277,941

0.05%

* Subscribed by his connected person, Kathleen Elizabeth Sharma

 

 

Application has been made for a total of 160,564,372 New Ordinary Shares, to be issued pursuant to the Transaction, to be admitted to trading on AIM. It is expected that Admission and dealings in the 160,564,372 New Ordinary Shares will commence on or around 8.00 a.m. on 26 May 2023. Following Admission, the Enlarged Share Capital of the Company will consist of 592,416,192 Ordinary Shares, none of which are held in treasury. Therefore, the total number of voting rights in the Company will be 592,416,192 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.

This announcement should be read in conjunction with the full text of the Circular posted to Shareholders on 9 May 2023, copies of which are available on the Company's website at: www.kromek.com/investor-relations. The same definitions apply throughout this announcement as are applied in the Circular.

 

For further information, please contact:

 

Kromek Group plc

 

Arnab Basu, CEO

Paul Farquhar, CFO

 

+44 (0)1740 626 060

finnCap Ltd (Nominated Adviser and Broker)

 

Geoff Nash/Emily Watts/Seamus Fricker/ George Dollemore - Corporate Finance

Tim Redfern/Charlotte Sutcliffe - ECM

 

+44 (0)20 7220 0500

Gracechurch Group (Financial PR)

 

Harry Chathli/Claire Norbury

 

+44 (0)20 4582 3500

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rakesh Sharma

2. 

Reason for the Notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 penny each

Identification code

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5p

400,000

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above 

 

e)

Date of the transaction

25 May 2023

f)

Place of the transaction

London Stock Exchange, AIM Market

 

 

 1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Arnab Basu

2. 

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 penny each

Identification code

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5p

100,000

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above 

 

e)

Date of the transaction

25 May 2023

f)

Place of the transaction

London Stock Exchange, AIM Market

 

 

 1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Farquhar

2. 

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 penny each

Identification code

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5p

100,000

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above 

 

e)

Date of the transaction

25 May 2023

f)

Place of the transaction

London Stock Exchange, AIM Market

 

 

 1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Lawrence Kinet

2. 

Reason for the Notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 penny each

Identification code

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5p

400,000

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above 

 

e)

Date of the transaction

25 May 2023

f)

Place of the transaction

London Stock Exchange, AIM Market

 

 

 1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jerel Whittingham

2. 

Reason for the Notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 penny each

Identification code

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5p

300,000

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above 

 

e)

Date of the transaction

25 May 2023

f)

Place of the transaction

London Stock Exchange, AIM Market

 

 

 1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Christopher Wilks

2. 

Reason for the Notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 penny each

Identification code

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5p

100,000

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above 

 

e)

Date of the transaction

25 May 2023

f)

Place of the transaction

London Stock Exchange, AIM Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVSOROSUVUAR
Date   Source Headline
25th Apr 20247:00 amRNSKromek receives new Nuclear Security contract
3rd Apr 20243:13 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSKromek receives $2.1m security screening order
6th Mar 20243:21 pmRNSHolding(s) in Company
4th Mar 202412:16 pmRNSHolding(s) in Company
4th Mar 202411:51 amRNSResult of General Meeting
5th Feb 202410:17 amRNSConversion of £1.5m of Convertible Loan Notes
5th Feb 20247:00 amRNSKromek granted £1.3m under Horizon Europe scheme
30th Jan 20247:00 amRNSInterim Results
25th Jan 20247:00 amRNSKromek receives £1.4m CBRN order for EU stockpile
23rd Jan 20247:00 amRNSNotice of Results
18th Jan 20247:00 amRNSKromek receives $1.6m in advanced imaging orders
7th Nov 20237:00 amRNSCollaboration agreement with new CT partner
31st Oct 20237:00 amRNSKromek receives additional $1m in CBRN orders
26th Oct 20237:00 amRNSFirst US DHS Contract for Biosecurity for $5.9m
9th Oct 20234:59 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSHolding(s) in Company
28th Sep 202311:25 amRNSResult of AGM
28th Sep 20237:00 amRNSFinancing Update
14th Sep 20237:00 amRNSPartial Conversion of Convertible Loan Notes
12th Sep 20237:00 amRNSKromek detectors in new Spectrum Dynamics scanner
1st Sep 20235:00 pmRNSNotice of AGM and Publication of Annual Report
24th Jul 20237:01 amRNSFinal Results
24th Jul 20237:00 amRNSAppointment of Joint Broker
5th Jun 20237:00 amRNSNew $1.5m CBRN contract in Asia
31st May 20239:05 amRNSHolding(s) in Company
25th May 20232:48 pmRNSResult of Open Offer, General Meeting and TVR
10th May 20231:39 pmRNSNotice of Investor Webinar
5th May 20233:46 pmRNSPlacing, Subscription, Open Offer and Notice of GM
2nd May 20237:00 amRNSKromek receives medical imaging order of c.$1.4m
19th Apr 20237:00 amRNSKromek and Analogic Collaboration Agreement
18th Apr 20237:01 amRNSTrading Update
18th Apr 20237:00 amRNSSeven-Year Agreement with Tier 1 OEM
29th Mar 20237:00 amRNSKromek secures orders totalling over $1m
22nd Mar 20232:51 pmRNSHolding(s) in Company
31st Jan 20237:00 amRNSKromek awarded c. £2.5m by Innovate UK
31st Jan 20237:00 amRNSInterim Results
9th Jan 20237:00 amRNSKromek Secures $0.8m Order for D3S ID
19th Dec 20227:00 amRNSFurther agreement with Smiths Detection
15th Dec 20229:32 amEQSKromek Group 'delighted' with new contracts
12th Dec 20227:00 amRNSKromek wins £1.5m in nuclear security contracts
16th Nov 20227:00 amRNSAward of £5m bio-threat contract by UK Government
10th Nov 20227:00 amRNSKromek awarded US nuclear security contract
17th Oct 202211:42 amRNSKromek detectors used in digital SPECT/CT scanner
28th Sep 202212:27 pmRNSResult of AGM
2nd Sep 20225:26 pmRNSNotice of AGM and Publication of Annual Report
23rd Aug 202211:10 amRNSFundraising of £1.14 million
5th Aug 20227:00 amRNSFundraising of £1.7m
3rd Aug 20222:05 pmRNSSecond Price Monitoring Extn
3rd Aug 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.